Clinical characteristics of primary cutaneous and subcutaneous Ewing sarcoma
被引:2
|
作者:
论文数: 引用数:
h-index:
机构:
Aiba, Hisaki
[1
,2
]
Kojima, Yuki
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Med Oncol, Tokyo, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Kojima, Yuki
[1
]
Shimoi, Tatsunori
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Med Oncol, Tokyo, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Shimoi, Tatsunori
[1
]
Sudo, Kazuki
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Med Oncol, Tokyo, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Sudo, Kazuki
[1
]
Yazaki, Shu
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Med Oncol, Tokyo, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Yazaki, Shu
[1
]
Imai, Toru
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Med Oncol, Tokyo, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Imai, Toru
[1
]
Yoshida, Akihiko
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Diagnost Pathol, Tokyo, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Yoshida, Akihiko
[3
]
Iwata, Shintaro
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Musculoskeletal Oncol & Rehabil, Tokyo, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Iwata, Shintaro
[4
]
Kobayashi, Eisuke
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Musculoskeletal Oncol & Rehabil, Tokyo, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Kobayashi, Eisuke
[4
]
Kawai, Akira
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Musculoskeletal Oncol & Rehabil, Tokyo, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Kawai, Akira
[4
]
Arakawa, Ayumu
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Pediat Oncol, Tokyo, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Arakawa, Ayumu
[5
]
Ogawa, Chitose
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Pediat Oncol, Tokyo, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Ogawa, Chitose
[5
]
Kimura, Hiroaki
论文数: 0引用数: 0
h-index: 0
机构:
Nagoya City Univ, Dept Orthopaed Surg, Nagoya, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Kimura, Hiroaki
[2
]
Yonemori, Kan
论文数: 0引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Natl Canc Ctr, Dept Med Oncol, Tsukiji 5-1-1,Chuo Ku, Tokyo 1040045, JapanNatl Canc Ctr, Dept Med Oncol, Tokyo, Japan
Yonemori, Kan
[1
,6
]
机构:
[1] Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan
[2] Nagoya City Univ, Dept Orthopaed Surg, Nagoya, Japan
[3] Natl Canc Ctr, Dept Diagnost Pathol, Tokyo, Japan
[4] Natl Canc Ctr, Dept Musculoskeletal Oncol & Rehabil, Tokyo, Japan
[5] Natl Canc Ctr, Dept Pediat Oncol, Tokyo, Japan
[6] Natl Canc Ctr, Dept Med Oncol, Tsukiji 5-1-1,Chuo Ku, Tokyo 1040045, Japan
Cutaneous/subcutaneous Ewing sarcoma often undergo pre-diagnostic resection without appropriate investigation, but a combination of additional resection and radiotherapy can salvage the local control. Objective Given the rarity of cutaneous/subcutaneous Ewing sarcoma, their clinical characteristics remain poorly understood. In this study, we aimed to analyse the clinical characteristics of patients with cutaneous/subcutaneous Ewing sarcoma and review the treatment strategy. Methods We reviewed the clinical data of 154 patients with Ewing sarcoma who were treated at our hospital between 2005 and 2019. Amongst these patients, 21 patients with cutaneous/subcutaneous Ewing sarcoma were analysed. As a basic strategy, patients with localized disease received intensive chemotherapy (vincristine-doxorubicin-cyclophosphamide/ifosfamide-etoposide), followed by definitive surgery with or without radiotherapy. In total, 15 patients underwent pre-diagnostic resection with macroscopic residue (seven patients) or non-macroscopic residue (eight patients) before intensive chemotherapy. Results The median tumour length of the measurable lesions was 3.2 cm, and the ratio of metastasis was significantly lower than the Ewing sarcoma of other anatomical sites (10% vs. 37%, P = 0.013). Despite the pre-diagnostic resection, local recurrence after additional resection and/or adjuvant radiotherapy did not occur in any of the patients with localized disease. Overall survival was significantly higher in patients with cutaneous/subcutaneous Ewing sarcoma than in patients with Ewing sarcoma of other anatomical sites (hazard ratio = 0.33, P = 0.013). The event-free survival rate of cutaneous/subcutaneous Ewing sarcoma was also superior to that of Ewing sarcoma of other anatomical sites (hazard ratio = 0.35, P = 0.01). Conclusions Patients with cutaneous/subcutaneous Ewing sarcoma may have better prognosis than those with Ewing sarcoma at other anatomical sites. Although pre-diagnostic resection without appropriate investigations is not recommended, local control may be recovered by using a combination of additional resection, chemotherapy and radiotherapy.
机构:
Univ Autonoma Madrid, Fdn Jimenez Diaz, Dept Dermatol, Avd Reyes Catolicos 2, Madrid 28040, SpainUniv Autonoma Madrid, Fdn Jimenez Diaz, Dept Dermatol, Avd Reyes Catolicos 2, Madrid 28040, Spain
Molina-Ruiz, Ana M.
Busam, Klaus J.
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USAUniv Autonoma Madrid, Fdn Jimenez Diaz, Dept Dermatol, Avd Reyes Catolicos 2, Madrid 28040, Spain